Raymond James Maintains Strong Buy on Encompass Health, Raises Price Target to $85
Portfolio Pulse from richadhand@benzinga.com
Raymond James analyst John Ransom maintains a Strong Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $80 to $85.
August 04, 2023 | 1:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's price target has been raised from $80 to $85 by Raymond James, maintaining a Strong Buy rating.
The news of Raymond James maintaining a Strong Buy rating and raising the price target for Encompass Health is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100